![Scheme of CEA extraction and purification (a), and SDS-PAGE analysis of... | Download Scientific Diagram Scheme of CEA extraction and purification (a), and SDS-PAGE analysis of... | Download Scientific Diagram](https://www.researchgate.net/publication/279967155/figure/fig1/AS:267497819602945@1440787858112/Scheme-of-CEA-extraction-and-purification-a-and-SDS-PAGE-analysis-of-CEA-and-molecular.png)
Scheme of CEA extraction and purification (a), and SDS-PAGE analysis of... | Download Scientific Diagram
![Distribution, RIs of tumor marker levels, and 90% confidence intervals. | Download Scientific Diagram Distribution, RIs of tumor marker levels, and 90% confidence intervals. | Download Scientific Diagram](https://www.researchgate.net/publication/360717655/figure/tbl2/AS:1160019328409601@1653581568576/Distribution-RIs-of-tumor-marker-levels-and-90-confidence-intervals.png)
Distribution, RIs of tumor marker levels, and 90% confidence intervals. | Download Scientific Diagram
![Ultrasensitive Point‐of‐Care Test for Tumor Marker in Human Saliva Based on Luminescence‐Amplification Strategy of Lanthanide Nanoprobes - Zhou - 2021 - Advanced Science - Wiley Online Library Ultrasensitive Point‐of‐Care Test for Tumor Marker in Human Saliva Based on Luminescence‐Amplification Strategy of Lanthanide Nanoprobes - Zhou - 2021 - Advanced Science - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/77635b0a-56cb-4418-957e-eca37739da35/advs2223-gra-0001-m.jpg?trick=1676244816723)
Ultrasensitive Point‐of‐Care Test for Tumor Marker in Human Saliva Based on Luminescence‐Amplification Strategy of Lanthanide Nanoprobes - Zhou - 2021 - Advanced Science - Wiley Online Library
MedlinePlus - What are tumor marker tests? These tests look for tumor markers, sometimes called cancer markers, in the blood, urine, or body tissues. Tumor markers are substances made by cancer cells
![PDF] Prognostic Value of the Tumor Marker Index Based on Preoperative Serum Carcinoembryon-ic Antigen and Cytokeratin-19 Fragment Levels for Overall and Disease-Free Survival in Patients with Stage I Non-Small Cell Lung Cancer PDF] Prognostic Value of the Tumor Marker Index Based on Preoperative Serum Carcinoembryon-ic Antigen and Cytokeratin-19 Fragment Levels for Overall and Disease-Free Survival in Patients with Stage I Non-Small Cell Lung Cancer](https://d3i71xaburhd42.cloudfront.net/d2f4e9f1debc6a6bdbd7c11af1b651307f1e363b/4-Table4-1.png)
PDF] Prognostic Value of the Tumor Marker Index Based on Preoperative Serum Carcinoembryon-ic Antigen and Cytokeratin-19 Fragment Levels for Overall and Disease-Free Survival in Patients with Stage I Non-Small Cell Lung Cancer
![Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-018-21048-y/MediaObjects/41598_2018_21048_Fig1_HTML.jpg)
Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports
![CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01431-9/MediaObjects/41416_2021_1431_Fig1_HTML.png)
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer
![Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib Prognostic and predictive value of CEA and CYFRA 21-1 levels in advanced non-small cell lung cancer patients treated with gefitinib or erlotinib](https://www.spandidos-publications.com/article_images/etm/2/4/ETM-02-04-0685-g00.jpg)